J Korean Diabetes.  2011 Sep;12(3):150-153. 10.4093/jkd.2011.12.3.150.

Intraoperative and Postoperative Glycemic Management in Patients with Diabetes

Affiliations
  • 1Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea. okdom@jejunu.ac.kr

Abstract

Unlike minor operations, major surgeries require strict glycemic control using intravenous insulin infusion in patients with diabetes. The postoperative transition to subcutaneous insulin, if needed, can begin several hours before discontinuing intravenous insulin, by reinitiation of basal insulin re-initiation. Basal-bolus insulin regimens are safer and more effective in hospitalized patients than supplemental-scale regular insulin.

Keyword

Intraoperative care; Postoperative care; Hyperglycemia; Diabetes mellitus

MeSH Terms

Diabetes Mellitus
Humans
Hyperglycemia
Insulin
Intraoperative Care
Postoperative Care
Insulin

Cited by  1 articles

Glycemic Control in Cancer Patients
Kyung Ae Lee, Hong Sun Baek, Tae Sun Park
J Korean Diabetes. 2016;17(3):168-173.    doi: 10.4093/jkd.2016.17.3.168.


Reference

1. Markovitz LJ, Wiechmann RJ, Harris N, Hayden V, Cooper J, Johnson G, Harelstad R, Calkins L, Braithwaite SS. Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. Endocr Pract. 2002; 8:10–8.
Article
2. Goldberg PA, Siegel MD, Sherwin RS, Halickman JI, Lee M, Bailey VA, Lee SL, Dziura JD, Inzucchi SE. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004; 27:461–7.
Article
3. Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, Puig A, Mejia R. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007; 30:2181–6.
Article
Full Text Links
  • JKD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr